Advanced strategies of short-term prophylaxis in menstrual migraine: State of the art and prospects

Neurological Sciences

Volumn 26, Issue SUPPL. 2, 2005, Pages

  Allais, G ^a   Bussone, G ^b   De Lorenzo, C ^a   Mana, O ^a   Benedetto, C ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Coxibs; Hormones; Menstrual migraine; NSAIDs; Short term prophylaxis; Triptans

Indexed keywords

ANTIMIGRAINE AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DANAZOL; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FENOPROFEN; FROVATRIPTAN; GONADORELIN AGONIST; ISOFLAVONE; MAGNESIUM DERIVATIVE; MAGNESIUM PIRROLYDONE CARBOXYLIC ACID; MEFENAMIC ACID; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PHYTOESTROGEN; PLACEBO; PROSTAGLANDIN; ROFECOXIB; SUMATRIPTAN; TAMOXIFEN; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; GASTROINTESTINAL TOXICITY; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MIGRAINE; RECURRENCE RISK; STEROID BLOOD LEVEL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DYSMENORRHEA; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIGRAINE DISORDERS; PREVENTIVE MEDICINE; SEROTONIN AGONISTS; TIME FACTORS;

EID: 20444413409     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-005-0424-7     Document Type: Article

References (27)

1. MacGregor A (1999) Migraine in women. Martin Dunitz Ltd, London
2. Allais G, Benedetto C (2004) Update on menstrual migraine: From clinical aspects to therapeutical strategies. Neurol Sci 25[Suppl 3]:S229-S231
3. Granella F, Sances G, Allais G, Nappi RE, Tirelli A, Ferraris A et al (2004) Characteristics of menstrual and non-menstrual attacks in women with menstrually related migraine referred to headache centers. Cephalalgia 24:707-716
4. Somerville BW (1972) The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 22:355-365
5. MacGregor EA (1997) Menstruation, sex hormones and migraine. Neurol Clin 15:125-141
6. Benedetto C, Allais G, Ciochetto D, De Lorenzo C (1997) Pathophysiological aspects of menstrual migraine. Cephalalgia 17[Suppl 20]:34-38
7. Welch KMA (1997) Migraine and ovarian steroid hormones. Cephalalgia 17[Suppl 20]:12-16
8. Nattero G, Allais G, De Lorenzo C, Benedetto C, Zonca M, Melzi E et al (1989) Relevance of prostaglandins in true menstrual migraine. Headache 29:233-238
9. Nattero G, Allais G, De Lorenzo C, Ferrando M, Ferrari P, Benedetto C et al (1991) Biological and clinical effects of naproxen sodium in menstrual migraine. Cephalalgia 11[Suppl 11]:S201-202
10. Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G (1990) Naproxen sodium in menstrual migraine prophylaxis; a double-blind placebo controlled study. Headache 30:705-709
11. Von Seggern RL, Mannix LK, Adelman JU (2004) Rofecoxib in the prevention of perimenstrual migraine: An open-label pilot trial. Headache 44:160-165
12. Granella F, Allais G, Benedetto C (2003) Cyclo-oxygenase-2 inhibitors as short-term prophylaxis of menstrually related migraine. A pilot study. Cephalalgia 23:731 (Abstract)
13. Newman LC, Lipton RB, Lay CL, Solomon S (1998) A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 51:307-309
14. Newman LC, Mannix LK, Landy S, Silberstein S, Lipton RB, Pait Putnam DG et al (2001) Naratriptan as short-term prophylaxis of menstrually associated migraine: A randomized, doubleblind, placebo-controlled study. Headache 41:248-256
15. Moschiano F, Allais G, Grazzi L, Usai S, Benedetto C, D'Amico D et al (2005) Naratriptan in the cyclic prophylaxis of pure menstrual migraine. Neurol Sci 26[Suppl 2]:S162-S166
16. Silberstein S, Elkind AH, Schreiber C, Keywood C (2004) A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 63:261-269
17. Loder E (2002) Prophylaxis of menstrual migraine with triptans: Problems and possibilities. Neurology 59:1677-1681
18. Chavanu KJ, O'Donnel DC (2002) Hormonal interventions for menstrual migraines. Pharmacotherapy 22:1442-1457
19. De Lignières B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG (1986) Prevention of menstrual migraine by percutaneous oestradiol. Br Med J 293:1540
20. Calton GJ, Burnett JW (1984) Danazol and migraine. N Engl J Med 310:721-722
21. O'Dea JP, Davis EH (1990) Tamoxifen in the treatment of menstrual migraine. Neurology 40:1470-1471
22. Murray SC, Muse KN (1997) Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy. Fertil Steril 67:390-393
23. Martin V, Wernke S, Mandell K, Zoma W, Bean J, Pinney S et al (2003) Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 43:309-321
24. Silberstein SD, Merriam GR (1997) Sex hormones and headache. In: Goadsby PJ, Silberstein SD (eds) Headache. Butterworth-Heinemann, Boston, pp 143-173
25. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991) Magnesium prophylaxis of menstrual migraine: Effects on intracellular magnesium. Headache 31:298-301
26. Burke BE, Olson RD, Cusack BJ (2002) Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharmacother 56:283-288
27. Ferrante F, Fusco E, Calabresi P, Cupini LM (2004) Phytooestrogens in the prophylaxis of menstrual migraine. Clin Neuropharmacol 27:137-140